Skip to content
OpenCapital
Get started

Ultragenyx Pharmaceutical RARE Invested capital

Discontinued — last reported Q4 '25

Invested capital at other companies

Griffon logo
GriffonGFF
5.9%-9.9pp
Benchmark Electronics logo
Benchmark ElectronicsBHE
3.8%-1.7pp
Power Integrations logo
Power IntegrationsPOWI
1.5%-1.0pp
SSR Mining logo
SSR MiningSSRM
18.7%—
Repligen logo
RepligenRGEN
0.3%-6.3pp
MYR Group logo
MYR GroupMYRG
18.4%+13.4pp

Other financials

Income statement

See full
Revenue$136.0M-2.2%
Operating income-$169.0M-18.2%
Net income-$185.0M-22.5%
EPS (diluted)-$1.84-17.2%

Balance sheet

See full
Cash & equivalents$175.0M+37.8%
Total debt$36.0M-10.8%
Total equity-$236.0M-264%
Total assets$1.3B-1.2%

Cash flow

See full
Operating cash flow-$197.0M-18.7%
CapEx$1.0M0.0%
Free cash flow-$198.0M-18.6%

Valuation

See full
Market cap$2.83B-39.4%
P/S4.2×-3.7×

Profitability

See full
Gross margin97.2%—
Operating margin-83.8%-3.0pp
Net margin-90.9%-2.1pp
FCF margin-75.1%+10.7pp

Returns & leverage

See full
Return on equity-325.6%+36.9pp
Debt / equity3.7×—
Current ratio2×-0.4×

Where this comes from

Calculated from Ultragenyx Pharmaceutical’s reported figures.

$36.0Mtotal debt−$80.0Mtotal stockholders equity−$421.0Mcash and equivalents=-$465M

The official record: Ultragenyx Pharmaceutical’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ultragenyx Pharmaceutical's invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ultragenyx Pharmaceutical's invested capital?
Ultragenyx Pharmaceutical (RARE) reported invested capital of -$465M in Q4 2025.
How has Ultragenyx Pharmaceutical's invested capital changed year-over-year?
Ultragenyx Pharmaceutical's invested capital decreased by 483.2% year-over-year, from $121.34M to -$465M.
What is the long-term trend for Ultragenyx Pharmaceutical's invested capital?
Over 5 years (2020 to 2025), Ultragenyx Pharmaceutical's invested capital has grown at a -1.0% compound annual growth rate (CAGR), from $489.08M to -$465M.
What does invested capital mean?
Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).